Insider Trading activities of Stellar Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Stellar Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Stellar Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Stellar Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is SLXCF. The reporting company's CIK number is 1159019.
The total value of stock buying since 2005 is $3,095,514.
The total value of stock sales since 2005 is $81,404.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Stellar Pharmaceuticals Inc (SLXCF).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-03 5,000,000 $0 0 $0 0 $0
2013-02 3,437,500 $1,375,000 0 $0 0 $0
2012-11 100,000 $35,000 0 $0 0 $0
2012-09 130,000 $64,831 0 $0 0 $0
2012-08 895,000 $418,800 0 $0 0 $0
2012-03 2,000,000 $1,120,000 0 $0 0 $0
2011-11 0 $0 71,575 $37,787 0 $0
2011-10 0 $0 29,590 $13,690 0 $0
2011-07 12,620 $7,824 0 $0 0 $0
2011-04 103,735 $64,339 0 $0 0 $0
2010-08 0 $0 265 $227 0 $0
2010-06 0 $0 21,800 $19,620 0 $0
2007-09 20,000 $9,720 0 $0 0 $0
2006-06 0 $0 12,000 $10,080 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Stellar Pharmaceuticals Inc insiders (SLXCF)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-03-04 Gregory James M Buy 2,500,000 .00 0
2013-03-04 Gregory John M Buy 2,500,000 .00 0
2013-02-27 Harris Robert Paul (Chief Executive Officer) Buy 625,000 .40 250,000
2013-02-27 Elora Financial Management Inc. (CFO) Buy 62,500 .40 25,000
2013-02-27 Goldman Steven Harold (Director) Buy 1,250,000 .40 500,000
2013-02-27 Thrasher Francis Martin (Director) Buy 1,250,000 .40 500,000
2013-02-27 Tenney Arnold (Chairman) Buy 250,000 .40 100,000
2012-11-19 Goldman Steven Harold (Director) Buy 100,000 .35 35,000
2012-09-07 Goldman Steven Harold (Director) Buy 25,000 .50 12,500
2012-09-05 Goldman Steven Harold (Director) Buy 84,500 .50 42,081
2012-09-04 Goldman Steven Harold (Director) Buy 20,500 .50 10,250
2012-08-31 Goldman Steven Harold (Director) Buy 35,000 .48 16,800
2012-08-27 Goldman Steven Harold (Director) Buy 40,000 .38 15,200
2012-08-27 Tenney Arnold (Chairman) Buy 20,000 .38 7,600
2012-08-27 Palmer Susan Buy 400,000 .47 189,600
2012-08-27 Gregory John M Buy 400,000 .47 189,600
2012-03-22 Harris Robert Paul (Chief Executive Officer) Buy 1,100,000 .56 616,000
2012-03-22 Elora Financial Management Inc. (CFO) Buy 900,000 .56 504,000
2011-11-29 Riehl Peter Roy (10% Owner) Sale 25,000 .55 13,750
2011-11-28 Riehl Peter Roy (10% Owner) Sale 25,000 .53 13,250
2011-11-15 Riehl Peter Roy (10% Owner) Sale 14,275 .50 7,137
2011-11-09 Riehl Peter Roy (10% Owner) Sale 7,300 .50 3,650
2011-10-20 Riehl Peter Roy (10% Owner) Sale 9,590 .51 4,890
2011-10-18 Riehl Peter Roy (10% Owner) Sale 20,000 .44 8,800
2011-07-20 Riehl Peter Roy (10% Owner) Buy 12,620 .62 7,824
2011-04-21 Riehl Peter Roy (10% Owner) Buy 13,735 .72 9,889
2011-04-12 Riehl Peter Roy (10% Owner) Buy 50,000 .68 34,250
2011-04-05 Riehl Peter Roy (10% Owner) Buy 40,000 .50 20,200
2010-08-26 Goldman Steven Harold (Director) Sale 265 .86 227
2010-06-30 Clarke Janice Marie (Chief Financial Officer) Sale 21,800 .90 19,620
2007-09-24 Clarke Janice Marie (Chief Financial Officer) Buy 5,500 .52 2,860
2007-09-21 Clarke Janice Marie (Chief Financial Officer) Buy 4,500 .48 2,160
2007-09-21 Riehl Peter Roy (Chief Executive Officer) Buy 10,000 .47 4,700
2006-06-20 Rosenkrantz David Aubrey (Director) Sale 12,000 .84 10,080

Insider trading activities including stock purchases, stock sales, and option exercises of SLXCF listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Stellar Pharmaceuticals Inc (symbol SLXCF, CIK number 1159019) see the Securities and Exchange Commission (SEC) website.